Background: Little is understood regarding the inter-relation between economic, marital, and racial/ethnic differences in presentation and survival of surgically resected lung cancer patients. Our investigation will assess these differences in addition to known therapeutic, patient, and histopathologic factors.
specified; pneumonectomy with mediastinal node dissection; or pneumonectomy, not otherwise specified).
Outcome Variables and Other covariates
The outcome variables were overall survival (OS) and LCSS. Deaths from other causes were treated as censoring events. The main purpose of our investigation was to examine whether there are differences in presenting characteristics and outcomes in nine different ethnic groups by examining marital status, household income (<$50,000; $50-$74,999; >$75,000), type of insurance (insured, Medicaid, uninsured, unknown) in addition to established histopathologic and patient factors. Household income was listed in the SEER registry by median household income per county. The population was split into nine different ethnic groups as follows: White non-Hispanic (White), Black, White Hispanic (Hispanic), AI/AN, Chinese, Japanese, South Asian (Asian Indian and Pakistani), Other Asian (Filipino, Thai, Vietnamese, Korean, Kampuchean, Laotian, and Hmong), and Other Race (OR, Chamorran, Fiji Islander, Guamanian, Hawaiian, Melanesian, Micronesian, New Guinean, Pacific Islander, Polynesian, Samoan, Tahitian, Tongan, unknown, and other) in both the entire lung cancer surgical population as well as those presenting with ESR disease. We originally wanted to include black Hispanic patients as a separate patient category in this manuscript and its companion study assessing ethnic differences in all lung cancer patients and those with Stage IV disease, but since we wanted similar populations in both studies and because the number of Black Hispanic patients was scant in both the TS population and the ESR groups, we decided to include Black Hispanic patients in the Black category, similar to a past study (8) . Black Hispanic patients represented approximately 0.6% of patient group undergoing surgical resection (19/3,276). Throughout this manuscript, the term population(s) will refer to total population of surgical patients (TS) and those with ESR disease, while group(s) will refer to the nine different ethnicities. Variables examined for their potential effect on outcome were gender; age; year of diagnosis; marital status; race; ethnicity; tumor stage; t-stage, n-stage; nodes examined; nodes positive; node density (number of nodes positive/number of nodes examined); tumor size; histology; grade; SEER registry location; median family income; resection type; post-operative radiation; and tumor location. Median follow-up time was calculated by the methods of Schemper and Smith in which death becomes a censored follow-up time and was noted to be 36 and 35 months in the TS and ESR groups, respectively (9) .
statistical analysis
Chi-square and t-test were used to compare difference between the ethnic groups with respect to treatment, patient characteristics, and tumor characteristics. Cox proportional hazards models estimates (10) were used to calculate adjusted hazard ratios with their 95% confidence intervals, and to show how treatment and other covariates were related to OS and LCSS. Medicare eligibility was controlled through use of two strata for age at diagnosis (≥65 vs <65 years old) because individual cases will change when they enroll in Medicare. The cox proportional hazards assumption was checked by visual examination of survival plots.
(Continued) resUlTs
Presenting characteristics
Complete demographic and histologic details of the TS and ESR patients can be seen in Figure 1A . 
Os in the Total surgical Population
Multivariable analysis (MVA) for OS for TS population can be seen in Table 3 . Age (p < 0.0001, HR = 1.029) and male sex (p < 0.0001, HR = 1.453) were significantly associated with OS. OS was significantly better than Whites (HR = 0.693-0.843) in all groups except for AI/ANs, Japanese, Blacks, and Hispanics who had a similar OS. MVA-adjusted OS by ethic group can be seen in Figure 1B . As compared to Connecticut, worse survival was noted in California, Greater Georgia, Iowa, Kentucky, Louisiana, and Utah. OS was not income dependent. Insured patients had a better OS than those on Medicaid (p < 0.0001, HR = 1.286). Married patients had a better OS than divorced (p < 0.0001, HR = 1.191), widowed (p < 0.0001, HR = 1.229), and single patients (p < 0.0001, HR = 1.1215). As compared to Stage I, Stages II-IV were associated with a worse OS with a progressively increasing HR (all p < 0.0001, HR = 1.702-3.273). As compared to patients with adenocarcinoma, all histologies were associated with a worse OS (p < 0.0001 to <0.0008, HR = 1.119-1.564).
Using well-differentiated tumors as a reference, all other tumor grades were associated with a worse OS (all p < 0.0001, HR = 1.665-3.273). Segmentectomies and (bi)lobectomies were associated with a better OS than pneumonectomies, p = 0.0011, HR = 0.80; p < 0.0001, HR = 0.72, respectively. Patients who received radiation (p < 0.0001, HR = 1.162) experienced worse 
Os in the esr Population
Multivariable analysis for OS for ESR population can be seen in Table 4 . Age (p < 0.0001, HR = 1.034), and male sex (p < 0.0001, HR = 1.506) were significantly associated with OS. OS was significantly better than Whites in the Other Race (p = 0.0051, HR = 0.555) and Other Asian groups (p = 0.012, HR = 0.736), but it was similar in all other ethnic groups. As compared to Connecticut, worse survival was noted in California, Greater Georgia, Kentucky, Louisiana, and Utah. OS was not income dependent. Insured patients had a better OS than those on Medicaid (p < 0.0001, HR = 1.385). Married patients had a (Continued) 
lcss in the esr Population
Multivariate analysis for LCSS for ESR population can be seen in Table 5 . Age (p < 0.0001, HR = 1.023) and male sex (p < 0.0001, HR = 1.393) were significantly associated with LCSS. LCSS was not significantly associated with race or income. As compared to Connecticut, worse LCSS was noted in Greater Georgia, Kentucky, and Louisiana. Insured patients had a better LCSS than those on Medicaid (p < 0.0001, HR = 1.445). 
90-Day Mortality analysis
Multivariate analysis for 90-day OS for TS population can be seen in Table 6 . Age (p < 0.0001, HR = 1.045) and male sex (p < 0.0001, HR = 1.547) were significantly associated with 90-day OS. 90-day mortality was the same in all ethnic groups. Higher median income (>$75,000) was associated with a better survival. As compared to Connecticut, worse survival was noted in Louisiana and Utah. Using well-differentiated tumors as a reference, 90-day mortality was higher in patients having poorly differentiated, undifferentiated, and unknown differentiated tumors. Pneumonectomies were associated with a significantly higher 90-day mortality than all other resection types (p = 0.0281 to <0.0001, HR = 0.418-0.775), except for sub-lobar, NOS which had a higher mortality (p = 0.0012, HR = 1.885). Patients who received radiation experienced a significantly lower 90-day mortality (p < 0.0001, HR = 0.217). Number of nodes examined was associated with better OS (p = 0.0001, HR = 0.984), but number of nodes positive and lymph node density were associated with worse OS. Similar 90-day mortality was noted to 2007 for years 2008-2012.
characteristics associated With nodal Positivity
In Table 7 , a multivariate analysis was performed for the risk of having nodal positivity in patients undergoing a definitive surgical procedure with a T1-T2 tumor <2 cm and at least one lymph node examined. The results were adjusted for type of surgical resection. Age (p < 0.0001, HR = 1.036) and male sex (p < 0.0001, HR = 1.386) were significantly associated with positive nodes. Positive nodes were not associated with any ethnic or income group. As compared to Connecticut, a greater risk of positive nodes was found in Greater Georgia, Hawaii, and Utah. is currently unknown, but the all other populations had a similar or better (Japanese or Other Race) 30-day survival to the White population. Although the unadjusted 90-day mortality was lower in the Other Asian and Other Race populations, there was no difference between the other ethnic groups and the Whites. However, the MVA demonstrated that there was no significant difference between the ethnic groups as compared to Whites. It should be noted that we included stage IV patients in this analysis of patients undergoing a definitive surgical procedure because a satellite nodule in a different lobe of the ipsilateral lung was classified by the AJCC staging as metastatic until 2010 when the new AJCC seventh edition classified this situation as T4 (11) . The percentage of each ethnic group undergoing a definitive surgical procedure for Stage IV disease varied from 4.5 to 9.8%. Only the Hispanic group had significantly different percentage of Stage IV patients than the White patients (9.8% of Hispanics vs 6.9% of Whites). Two thousand five hundred sixty three patients with Stage IV tumors underwent a definitive surgical procedure. One thousand six hundred twenty-seven patients were classified as having tumors nodules in different ipsilateral lobes during the years 2007-2009. One thousand one hundred twenty-nine underwent a sub-lobar resection (966 wedge, 92 segmentectomy, and 71 sub-lobar, NOS). Although some patients may have undergone a diagnostic wedge procedure, we assume that most of the remaining patients who did not have tumor nodules in different ipsilateral lobes (N = 936) may have been found to have metastatic disease shortly after their surgical procedure. However, the performance of staging investigations and their timing in relation to surgical procedures is not available in SEER. Nevertheless, after removing the patients who would now be re-classified as having Stage III NSCLC, the numbers were too small for further characterization of these patients by ethnicity. It is interesting to note that the multivariable analyses for OS in the TS and ESR, and LCSS in the ESR populations yielded similar results to the multivariable analyses for OS in our companion manuscript containing two different lung cancer populations (all patients presenting with NSCLC and those presenting with Stage IV disease). In all four lung cancer populations in both manuscripts, well-established risk factors (12, 13) for OS and LCSS were noted in all multivariable analyses including tumor size, stage, differentiation, gender, age, and t-stage. After adjustment for histolopathologic, gender, age, treatment, and marital variables, all ethnicities in all analyses had similar or significantly better OS and LCSS (ESR group only) compared to the White group. Adenocarcinoma was uniformly associated with a better OS. A consistently lower OS and LCSS were noted for all four lung cancer populations in Greater Georgia, Louisiana, and Kentucky. Similarly, patients in California and Iowa had poorer outcomes except for OS in the Stage IV population in California and OS in the ESR group in Iowa. The reason for the consistently poor outcomes across all stages and presentations in these registries is currently not known, but we believe that the number physician per 100,000 may be a factor because all five states rank in the bottom half of states in terms of the density of total active physicians as well as primary care physicians (14) . Of interest, the highly significantly survival decrement (p < 0.0001) for tumor location in the mainstem bronchi in the companion manuscript was less significant in the surgical patients where only the right mainstem (p = 0.01) remained significant for OS in the TS group. There was no OS or LCSS decrement noted in the ESR population for the mainstem bronchi location. However, there was only a small number of tumors associated with the mainstem bronchi (N = 30) in the ESR group. We hypothesize that surgery neutralizes the effects of mainstem bronchi locations because this modality effectively eradicates a location that can cause obstructive pneumonias in a compromised patient group. Interestingly, although the companion paper noted that both lower lobe locations were noted to be associated with decreased OS, only the right lower lobe location was noted to be associated with worse OS in the surgical patients.
The association of the lower lobes with worse outcomes has been noted in other investigations (15, 16) . Our analysis demonstrates that the worse OS survival in patients having tumor located in the right lower lobe may be due to an increased risk of nodal involvement. Prognosis in all lung cancer populations was improved by being married, not having Medicaid, and being insured, but unlike the previous analysis, income was not correlated with LCSS and OS in the surgical patients in this investigation with the exception of borderline worse of OS in the TS population for those individuals with a median household income of <$50,000 (p = 0.0457). In addition, all lung cancer populations were noted to have a general improvement in OS during the years of this study. The improvement in the surgical populations may have been due to variables that are not contained within SEER such as improved staging, increased use of chemotherapy, and better post-operative care. However, the improved OS in the ESR group would argue against the increased use of adjuvant therapy because chemotherapy would be less likely to be used in this group (17, 18) . Likewise, it may be argued that better post-operative care did not contribute to the better OS of the TS population because the 90-day mortality did not improve during the years of this study. This manuscript was able to assess some treatment-related factors because SEER-18 does contain some variables related to radiation and surgery. Patients receiving pre-operative radiation were excluded because it was felt that this treatment could obscure/improve histolopathologic variables. Because SEER-18 does not contain information pertaining to chemotherapeutic treatment, we deliberately decided to separately assess a surgical sub-group of patients with tumors 4 cm or less without nodal involvement because these patients would be unlikely to receive chemotherapy (17, 18) . Furthermore, we decided to investigate LCSS as well in this group of early-stage patients because of their relatively high likelihood of surviving lung cancer and possibly succumbing to other smoking-related causes. Worse OS and LCSS were consistently noted after a pneumonectomy despite multivariable analyses that accounted for histopathologic, patient, and tumor location variables. The adverse survival of patients undergoing a pneumonectomy was identified in recent retrospective study that demonstrated that that the lower survival may be due to an increased risk of distal metastases (19). Although the immune effects of a larger lung cancer procedures such as pneumonectomy as compared to (bi)lobectomy and sub-lobar resections is not known, it has been shown that transthoracic surgery for esophageal cancer as compared to smaller and less invasive surgical procedures (gastrectomy for cancer and cholecystomy for benign gallstones) has been associated with a transient immunosuppression (increased T-cell apoptosis and decreased T-cell cytokine production) during post-operative days 1-3 (20) . Interestingly, a different research group noted that both transhiatal and transthoracic esophagectomies were associated with reduced TH1-type cytokine production on post-operative day 1, but depression of Th2-type cytokine was more profound with the latter procedure (21). In both surgical populations, the number of nodes examined was strongly correlated with OS and LCSS and was similarly noted in a past SEER analysis (22) . The better outcomes associated with an increasing number of nodes examined may be due to the removal of microscopic disease that may or may not be recognized (especially in the ESR group) by routine pathologic methods (23) , but because there is no OS with mediastinal lympadenectomy as compared to nodal sampling (24) , one might infer that the beneficial effects of lymph node examination may be due to upstaging cancers that would otherwise be classified as node negative. Post-operative radiation was associated with poorer OS and LCSS. Although past retrospective analyses have demonstrated a possible survival benefit for radiation therapy in patients with N2 disease (25, 26) , others have not (27) . However, there has been general agreement that post-operative radiation results in a survival decrement in patients with N0 and N1 disease (25, 26) . A recent retrospective investigation demonstrated that there was an OS benefit for postoperative radiation therapy for patients who experience a positive resection margin for all nodal stages (28) . We would assume that the patients who receive post-operative radiation therapy for nodal stages N0-N1 during the years of our study had a positive margin, but SEER does not have information concerning margin status, and our results show a strongly negative effect of radiation on OS and LCSS in the surgical patients. Although there may be negative selection factors (i.e., positive margin, lymphatic, and/ or vascular invasion) in the patients receiving radiation, it may be that radiation therapy has no efficacy and could possibly only have deleterious effects in the post-operative setting, especially in those with N0-N1 disease.
The MVA for 90-day OS revealed that mortality was not related to ethnicity, but was significantly correlated with single/ unmarried partner status, Medicaid or unknown insurance, and income. Nevertheless, several known histopathologic and patient prognostic factors associated with aggressive disease/ poor outcomes predicted 90-day mortality included increasing patient age, male sex, tumor differentiation, stage, and nonadenocarcinoma histology and suggest that aggressive tumor spread and/or understaging at the time of resection may be the reasons for poor early survival. However, because financial and partnership variables did affect 90-day mortality, one may conclude that patients may be able to improve their short-term survival by better economic and emotional support. Of interest, even after accounting for histopathologic characteristics, tumor locations in the right mainstem bronchus and right lower lobe were associated with a decrement in OS. We hypothesize that operative complications associated with these locations may be a reason why these sites adversely affect OS in the TS and ESR populations. Treatment-related factors related to an increased mortality included the performance of a pneumonectomy and less nodes examined. We decided to include radiation in this analysis because we felt that radiation could possible result in an increased early mortality. Interestingly, radiation was strongly associated with an improved 90-day survival which may be due to patient selection factors which are not acknowledged by SEER including a better ECOG performance status, less co-morbidities, and lower risk of immediate post-operative infections. Early mortality did not improve during the years of our investigation suggesting that post-operative care was not associated with the improved outcomes in surgical patients. The decision to assess tumors generally considered eligible for a sub-lobar resection (T1-T2 tumors <2 cm in size) was made in order to assess which patients would benefit from a lymphadenectomy. Not surprisingly, nodal positivity was associated with known prognostic factors including advanced age, male sex, t-stage, aggressive histologies (adenosquamous, large cell, and squamous carcinomas), and tumor differentiation. Importantly, it should be noted that ethnicity was not associated with an increased risk of having positive nodes. Although income was not associated with nodal positivity, not being insured and not being married were both strongly associated with having node involvement. Because this analysis revealed that the right lower lobe location was associated with positive nodes, we believe that this may be a reason why this location is associated with a lower OS in both the TS and ESR populations.
We originally performed this analysis to assess the effects of the presentation and outcome differences by ethnicity as compared to Whites in patients undergoing surgical resection for lung cancer. In comparison to White patients, OS, LCSS, and 90-day mortality were similar or better in all ethnic groups for all three analyses. Median household income was largely not associated with OS or LCSS in the TS and ESR patients, but was strongly associated with 90-day mortality. Because this variable was assigned to patients based upon the median county income, we assume this variable may have adversely affected 90-day survival due to the hospital care received in more wealthy and less affluent areas. Of importance, Medicaid insurance and not being married were associated with lower OS and LCSS as well as an increased risk of 90-day mortality. We feel that not Medicaid insurance is more likely to represent an individual's economic status and demonstrates the importance of having insurance. However, of great interest, is that having Medicaid and not being married are factors that were also associated with an increased risk of nodal involvement. This suggests that economic and psychological factors can possibly be associated with lung cancer biology. Lower socioeconomic status may affect tumor biology through poor nutrition (29) . Recently, it was noted that unmarried lung cancer patients had a greater incidence of depression, less social support, and a survival decrement (30) , and that the survival decrement noted in patients with new-onset or persistent depression may be more so in early-stage (Stages I-II) than in patients with more advanced stages (31) . We feel that our results suggest that the economic effects of not having insurance and not being married are associated with real changes in tumor biology and aggressiveness.
It should be noted that the SEER database lacks may variables that would have been useful for our analysis including smoking history, body mass index, ECOG performance status, lymphatic and/or vascular invasion, patient co-morbidities, chemotherapy administration, type of surgical procedure (i.e., VATS, robotic surgery, and traditional thoracotomy), radiation dose, and radiation field arrangement. However, we have no reasons to think that any of these variables would have influenced our outcomes because we could account for median household income, type of insurance, and most major histopathologic variables.
In summary, the main purpose of our investigation was to assess difference in outcomes (OS and 30/90 day mortality), presentation, and treatment in nine different ethnic groups who underwent surgical resection of NSCLC. As a secondary aim, we also wanted to assess whether tumor biology (nodal involvement) varied by ethnicity. Even in the analyses that were not adjusted for treatment, histopathologic, patient, and marital factors; Blacks and Hispanics had the same OS and LCSS as the White group. We did not find disparities due to ethnicity in patients undergoing surgical resection for NSCLC, but noted that the disparities may be due to having Medicaid insurance and not being married. Because having Medicaid insurance and not being married were associated with lower OS, LCSS and 90-day OS as well as nodal positivity, we feel that economic and psychosocial variables may play a role in the biological aggressiveness of early-stage lung cancer patients undergoing resection in addition to standard histopathologic and treatment variables. Although marriage was equally as important as socioeconomic factors in our assessment, a study from an earlier time period (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) suggested that lower socioeconomic status was an independent prognostic factor, but marriage was note (32) . However, this past investigation by Ou et al. also noted that race was not a prognostic factor in multivariate modeling.
cOnclUsiOn
In TS and ESR populations, OS was not different in the two largest ethnic groups (Black, Hispanic) as compared to Whites, but was related to single/divorced status, medicaid insurance, and income (TS population only). Nodal positivity was associated with patients who did not have a married partner or insurance suggesting that these factors may impact disease biology. Economic and psychosocial variables may play a role in survival of early-stage lung cancer in addition to standard histopathologic and treatment variables.
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